Availability and Accessibility of Orphan Medicinal Products to Patients in Slovakia in the Years 2010-2019.

ABSTRACT: Objective: Information about the access of Slovak patients to orphan medicinal products (OMPs) in the literature is rather scarce. The main aim of the study was to analyze the accessibility and availability of OMPs to Slovak patients in the years 2010-2019. Methods: The analyzed OMPs were strictly defined according to the European definition. The date of marketing authorization together with its first appearance in the positive drug list was used to count the time to reach the national market. The data from the National Health Information Centre, the Ministry of Health, and health insurance companies were used as data sources of drug usage, expenditure, consumption, reimbursement of OMPs, as well as the total number of treated patients. Results: Out of the 167 OMPs on

SUBMITTER: Foltanova T 

PROVIDER: S-EPMC8826087 | biostudies-literature | 2022

REPOSITORIES: biostudies-literature